123 related articles for article (PubMed ID: 36764643)
1. Development of solid dispersions based on 3- (2,6-difluorobenzyl) -5- (5-bromo-1H-indol-3-ylmethylene) thiazolidine-2,4-dione for schistosomicidal treatment.
Paulino S; Santos L; Rabello M; da Silva P; Oliveira J; Lima MDC; Rocha T; Albuquerque M; Santos V; Alves L; Brayner F; Gomes T; Aires A; Neto PR; Silva R
Exp Parasitol; 2023 May; 248():108455. PubMed ID: 36764643
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of the in vitro schistosomicidal activity of solid dispersions based on 2-(-5-bromo-1-H-indole-3-yl-methylene)-N-(naphthalene-1-ylhydrazine-carbothiamide.
de Luna Rocha TC; Dos Santos Lima MJ; Nunes do Nascimento JL; Ferreira de Oliveira J; de Oliveira Silva E; Barbosa Dos Santos VH; de Lima Aires A; de Albuquerque Wanderley Sales V; Atanazio Rosa T; Rolim Neto PJ; Camelo Pessôa de Azevedo Albuquerque M; Alves de Lima MDC; Ferreira da Silva RM
Exp Parasitol; 2024 Jan; 256():108626. PubMed ID: 37972848
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
5. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
6. Solid dispersions of imidazolidinedione by PEG and PVP polymers with potential antischistosomal activities.
Guedes FL; de Oliveira BG; Hernandes MZ; De Simone CA; Veiga FJ; de Lima Mdo C; Pitta IR; Galdino SL; Neto PJ
AAPS PharmSciTech; 2011 Mar; 12(1):401-10. PubMed ID: 21360315
[TBL] [Abstract][Full Text] [Related]
7. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.
Dos Santos KM; Barbosa RM; Vargas FGA; de Azevedo EP; Lins ACDS; Camara CA; Aragão CFS; Moura TFLE; Raffin FN
Drug Dev Ind Pharm; 2018 May; 44(5):750-756. PubMed ID: 29206496
[TBL] [Abstract][Full Text] [Related]
8. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersions to enhance the delivery of a potential drug candidate LPSF/FZ4 for the treatment of schistosomiasis.
Schver GCRM; Sun DD; Costa SPM; Silva KER; Oliveira JF; Rolim LA; de Azevedo Albuquerque MCP; de Lima Aires A; Lima MDCA; Pitta IR; Lee PI; Rolim-Neto PJ
Eur J Pharm Sci; 2018 Mar; 115():270-285. PubMed ID: 29331607
[TBL] [Abstract][Full Text] [Related]
10. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
11. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
13. Formulation and characterization of glipizide solid dosage form with enhanced solubility.
Alotaibi BS; Khan MA; Ullah K; Yasin H; Mannan A; Khan SA; Murtaza G
PLoS One; 2024; 19(2):e0297467. PubMed ID: 38394326
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.
Yadav PS; Kumar V; Singh UP; Bhat HR; Mazumder B
Saudi Pharm J; 2013 Jan; 21(1):77-84. PubMed ID: 24109206
[TBL] [Abstract][Full Text] [Related]
15. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
16. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
17. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
18. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
19. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]